Delivery Order SPE2DB24D2205-SPE2DB25FEFCA
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,198.80, is for the supply of Vemlidy 25 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,473.77 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets, a medication used in the treatment of Hepatitis B. The contract has an ultimate completion date of May 9, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Vemlidy 25 mg tablets. The $4,183.18 firm fixed-price contract has an ultimate completion date of May 14, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for various...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,809.55, is for the supply of Vemlidy 25 mg tablets. The contract is a firm fixed-price delivery order with a completion date of June 11, 2024. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp's Corporate Office division. The $21,147.99 firm-fixed-price delivery order is for the supply of 4,565,091 units of the prescription medication Vemlidy 25 mg tablets. The contract has a period of performance through July 9, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $77,861.38 delivery order contract is for Vemlidy 25mg tablets, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Vemlidy 25 mg tablets. The contract, valued at $10,975.25, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. This...
- This federal contract award, valued at $10,052.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Vemlidy 25 mg Tablet, with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Vemlidy 25 mg tablets. The contract, which has a total ceiling value of $3,328.71, is a firm fixed-price delivery order with a completion date of July 11, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,957.98 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets. The contract has an ultimate completion date of August 13, 2021 and was awarded on August 12, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFCADelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price contract, valued at $15,138.05, represents a competitive award with no set-aside designation and an ultimate completion date of July 21, 2025. The award is classified as a child contract, indicating it derives from a larger prime contract vehicle. AmerisourceBergen maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the overarching pharmaceutical support vehicle enabling the delivery of this and similar pharmaceutical orders across military healthcare systems worldwide. The Defense Logistics Agency, operating under the Department of Defense, procures pharmaceutical products and medical supplies through its Medical Supply Chain to support military and veteran healthcare operations. Vemlidy, an antiviral hepatitis B medication, fulfills critical pharmaceutical needs within the federal medical procurement portfolio. AmerisourceBergen's role as a major pharmaceutical distributor ensures consistent delivery of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency customers and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 7/18/25 |